NCT02891863View on ClinicalTrials.gov

Low Energy Therapy to Convert Ventricular Tachycardias

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Ventricular Tachycardia
Interventions
DEVICE

LEVER Acute Study System

The LEVER Acute Study System is an acute pacing and shock delivery system intended for investigational use only. The LEVER Acute Study System is intended for acute conversion testing of monomorphic ventricular tachycardia by one of three different VT conversion methods.

Trial Locations (1)

Unknown

Royal Adelaide Hospital, Adelaide

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT02891863 - Low Energy Therapy to Convert Ventricular Tachycardias | Biotech Hunter | Biotech Hunter